PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Statistics

Total Valuation

IDX:MEDS has a market cap or net worth of IDR 146.88 billion. The enterprise value is 153.66 billion.

Market Cap	146.88B
Enterprise Value	153.66B

Important Dates

The next estimated earnings date is Friday, July 17, 2026.

Earnings Date	Jul 17, 2026
Ex-Dividend Date	n/a

Share Statistics

IDX:MEDS has 1.56 billion shares outstanding.

Current Share Class	1.56B
Shares Outstanding	1.56B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.17%
Owned by Institutions (%)	n/a
Float	669.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.33
PB Ratio	3.02
P/TBV Ratio	3.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-24.63
EV / Sales	16.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.43

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.14.

Current Ratio	1.19
Quick Ratio	0.26
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-1.42
Interest Coverage	-9.84

Financial Efficiency

Return on equity (ROE) is -12.06% and return on invested capital (ROIC) is -12.49%.

Return on Equity (ROE)	-12.06%
Return on Assets (ROA)	-6.74%
Return on Invested Capital (ROIC)	-12.49%
Return on Capital Employed (ROCE)	-13.93%
Weighted Average Cost of Capital (WACC)	10.56%
Revenue Per Employee	532.37M
Profits Per Employee	-346.57M
Employee Count	18
Asset Turnover	0.15
Inventory Turnover	0.63

Taxes

Income Tax	-221.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +88.00% in the last 52 weeks. The beta is 1.17, so IDX:MEDS's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+88.00%
50-Day Moving Average	75.94
200-Day Moving Average	71.71
Relative Strength Index (RSI)	52.01
Average Volume (20 Days)	298,845,995

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:MEDS had revenue of IDR 9.58 billion and -6.24 billion in losses. Loss per share was -3.99.

Revenue	9.58B
Gross Profit	1.83B
Operating Income	-6.93B
Pretax Income	-6.46B
Net Income	-6.24B
EBITDA	-2.94B
EBIT	-6.93B
Loss Per Share	-3.99

Balance Sheet

The company has 177.54 million in cash and 6.96 billion in debt, with a net cash position of -6.78 billion or -4.34 per share.

Cash & Cash Equivalents	177.54M
Total Debt	6.96B
Net Cash	-6.78B
Net Cash Per Share	-4.34
Equity (Book Value)	48.62B
Book Value Per Share	31.12
Working Capital	2.69B

Cash Flow

In the last 12 months, operating cash flow was -2.77 billion and capital expenditures -2.12 billion, giving a free cash flow of -4.89 billion.

Operating Cash Flow	-2.77B
Capital Expenditures	-2.12B
Depreciation & Amortization	3.99B
Net Borrowing	1.32B
Free Cash Flow	-4.89B
FCF Per Share	-3.13

Margins

Gross margin is 19.07%, with operating and profit margins of -72.29% and -65.10%.

Gross Margin	19.07%
Operating Margin	-72.29%
Pretax Margin	-67.42%
Profit Margin	-65.10%
EBITDA Margin	-30.67%
EBIT Margin	-72.29%
FCF Margin	n/a

Dividends & Yields

IDX:MEDS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.25%
FCF Yield	-3.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDX:MEDS has an Altman Z-Score of 3.51 and a Piotroski F-Score of 3.

Altman Z-Score	3.51
Piotroski F-Score	3